Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Catalano

Showing results (341-350 of 424) with videos related to

Pageof 43
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitorsW J Magner, A L Kazim, C Stewart, et al.
Anticancer Research|March 28, 2001
Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapyS Cascinu, F Graziano, V Catalano, et al.
La Clinica Terapeutica|August 15, 1984
[Tumor markers. Current use in antineoplastic strategy]L Manguso, M Musset, F Coraggio, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 12, 2023
A novel multisensory device for the assessment and rehabilitation of perceptual and attentional competenciesF Morelli, N Balzarotti, M Guarischi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignanciesP Comella, G Palmieri, V Lorusso, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 20, 2016
Frequency and characteristics of diabetes in 300 pre-liver transplant patientsL Marselli, P De Simone, R Morganti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: a phase I study of the Southern Italy Cooperative Oncology GroupP Comella, R Casaretti, F De Vita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracilS Cascinu, C Aschele, S Barni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancerG Tortora, F Ciardiello, V Damiano, et al.
Transplantation Proceedings|December 29, 2004
An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipientsF Vannozzi, F Filipponi, A Di Paolo, et al.
Pageof 43

Showing results (341-350 of 424) with videos related to

Sort By:
Pageof 43
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitorsW J Magner, A L Kazim, C Stewart, et al.
Anticancer Research|March 28, 2001
Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapyS Cascinu, F Graziano, V Catalano, et al.
La Clinica Terapeutica|August 15, 1984
[Tumor markers. Current use in antineoplastic strategy]L Manguso, M Musset, F Coraggio, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 12, 2023
A novel multisensory device for the assessment and rehabilitation of perceptual and attentional competenciesF Morelli, N Balzarotti, M Guarischi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignanciesP Comella, G Palmieri, V Lorusso, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 20, 2016
Frequency and characteristics of diabetes in 300 pre-liver transplant patientsL Marselli, P De Simone, R Morganti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: a phase I study of the Southern Italy Cooperative Oncology GroupP Comella, R Casaretti, F De Vita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracilS Cascinu, C Aschele, S Barni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancerG Tortora, F Ciardiello, V Damiano, et al.
Transplantation Proceedings|December 29, 2004
An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipientsF Vannozzi, F Filipponi, A Di Paolo, et al.
Pageof 43